Global Dengue Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Dengue Vaccines market size was valued at USD 412.2 million in 2023 and is forecast to a readjusted size of USD 1010.9 million by 2030 with a CAGR of 13.7% during review period.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
The Global Info Research report includes an overview of the development of the Dengue Vaccines industry chain, the market status of Public Sector (Dengvaxia, TAK-003), Private Sector (Dengvaxia, TAK-003), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dengue Vaccines.
Regionally, the report analyzes the Dengue Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dengue Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dengue Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dengue Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dengvaxia, TAK-003).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dengue Vaccines market.
Regional Analysis: The report involves examining the Dengue Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dengue Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dengue Vaccines:
Company Analysis: Report covers individual Dengue Vaccines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dengue Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public Sector, Private Sector).
Technology Analysis: Report covers specific technologies relevant to Dengue Vaccines. It assesses the current state, advancements, and potential future developments in Dengue Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dengue Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Dengue Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin and global market share of Dengue Vaccines from 2019 to 2024.
Chapter 3, the Dengue Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Dengue Vaccines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Vaccines.
Chapter 13, to describe Dengue Vaccines research findings and conclusion.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
The Global Info Research report includes an overview of the development of the Dengue Vaccines industry chain, the market status of Public Sector (Dengvaxia, TAK-003), Private Sector (Dengvaxia, TAK-003), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dengue Vaccines.
Regionally, the report analyzes the Dengue Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dengue Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dengue Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dengue Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dengvaxia, TAK-003).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dengue Vaccines market.
Regional Analysis: The report involves examining the Dengue Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dengue Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dengue Vaccines:
Company Analysis: Report covers individual Dengue Vaccines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dengue Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public Sector, Private Sector).
Technology Analysis: Report covers specific technologies relevant to Dengue Vaccines. It assesses the current state, advancements, and potential future developments in Dengue Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dengue Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Dengvaxia
- TAK-003
- Others
- Public Sector
- Private Sector
- Sanofi
- Takeda
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Dengue Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin and global market share of Dengue Vaccines from 2019 to 2024.
Chapter 3, the Dengue Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Dengue Vaccines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Vaccines.
Chapter 13, to describe Dengue Vaccines research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Dengue Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dengue Vaccines by Type
1.3.1 Overview: Global Dengue Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Dengue Vaccines Consumption Value Market Share by Type in 2023
1.3.3 Dengvaxia
1.3.4 TAK-003
1.3.5 Others
1.4 Global Dengue Vaccines Market by Application
1.4.1 Overview: Global Dengue Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public Sector
1.4.3 Private Sector
1.5 Global Dengue Vaccines Market Size & Forecast
1.6 Global Dengue Vaccines Market Size and Forecast by Region
1.6.1 Global Dengue Vaccines Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Dengue Vaccines Market Size by Region, (2019-2030)
1.6.3 North America Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.4 Europe Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.6 South America Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Dengue Vaccines Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dengue Vaccines Product and Solutions
2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Dengue Vaccines Product and Solutions
2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Dengue Vaccines Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Dengue Vaccines by Company Revenue
3.2.2 Top 3 Dengue Vaccines Players Market Share in 2023
3.2.3 Top 6 Dengue Vaccines Players Market Share in 2023
3.3 Dengue Vaccines Market: Overall Company Footprint Analysis
3.3.1 Dengue Vaccines Market: Region Footprint
3.3.2 Dengue Vaccines Market: Company Product Type Footprint
3.3.3 Dengue Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Dengue Vaccines Consumption Value and Market Share by Type (2019-2024)
4.2 Global Dengue Vaccines Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Dengue Vaccines Consumption Value Market Share by Application (2019-2024)
5.2 Global Dengue Vaccines Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Dengue Vaccines Consumption Value by Type (2019-2030)
6.2 North America Dengue Vaccines Consumption Value by Application (2019-2030)
6.3 North America Dengue Vaccines Market Size by Country
6.3.1 North America Dengue Vaccines Consumption Value by Country (2019-2030)
6.3.2 United States Dengue Vaccines Market Size and Forecast (2019-2030)
6.3.3 Canada Dengue Vaccines Market Size and Forecast (2019-2030)
6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Dengue Vaccines Consumption Value by Type (2019-2030)
7.2 Europe Dengue Vaccines Consumption Value by Application (2019-2030)
7.3 Europe Dengue Vaccines Market Size by Country
7.3.1 Europe Dengue Vaccines Consumption Value by Country (2019-2030)
7.3.2 Germany Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.3 France Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.5 Russia Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.6 Italy Dengue Vaccines Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Dengue Vaccines Market Size by Region
8.3.1 Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2030)
8.3.2 China Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.3 Japan Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.5 India Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.7 Australia Dengue Vaccines Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Dengue Vaccines Consumption Value by Type (2019-2030)
9.2 South America Dengue Vaccines Consumption Value by Application (2019-2030)
9.3 South America Dengue Vaccines Market Size by Country
9.3.1 South America Dengue Vaccines Consumption Value by Country (2019-2030)
9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2019-2030)
9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Dengue Vaccines Market Size by Country
10.3.1 Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2030)
10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2019-2030)
10.3.4 UAE Dengue Vaccines Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Dengue Vaccines Market Drivers
11.2 Dengue Vaccines Market Restraints
11.3 Dengue Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Dengue Vaccines Industry Chain
12.2 Dengue Vaccines Upstream Analysis
12.3 Dengue Vaccines Midstream Analysis
12.4 Dengue Vaccines Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Dengue Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dengue Vaccines by Type
1.3.1 Overview: Global Dengue Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Dengue Vaccines Consumption Value Market Share by Type in 2023
1.3.3 Dengvaxia
1.3.4 TAK-003
1.3.5 Others
1.4 Global Dengue Vaccines Market by Application
1.4.1 Overview: Global Dengue Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public Sector
1.4.3 Private Sector
1.5 Global Dengue Vaccines Market Size & Forecast
1.6 Global Dengue Vaccines Market Size and Forecast by Region
1.6.1 Global Dengue Vaccines Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Dengue Vaccines Market Size by Region, (2019-2030)
1.6.3 North America Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.4 Europe Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.6 South America Dengue Vaccines Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Dengue Vaccines Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dengue Vaccines Product and Solutions
2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Dengue Vaccines Product and Solutions
2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Dengue Vaccines Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Dengue Vaccines by Company Revenue
3.2.2 Top 3 Dengue Vaccines Players Market Share in 2023
3.2.3 Top 6 Dengue Vaccines Players Market Share in 2023
3.3 Dengue Vaccines Market: Overall Company Footprint Analysis
3.3.1 Dengue Vaccines Market: Region Footprint
3.3.2 Dengue Vaccines Market: Company Product Type Footprint
3.3.3 Dengue Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Dengue Vaccines Consumption Value and Market Share by Type (2019-2024)
4.2 Global Dengue Vaccines Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Dengue Vaccines Consumption Value Market Share by Application (2019-2024)
5.2 Global Dengue Vaccines Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Dengue Vaccines Consumption Value by Type (2019-2030)
6.2 North America Dengue Vaccines Consumption Value by Application (2019-2030)
6.3 North America Dengue Vaccines Market Size by Country
6.3.1 North America Dengue Vaccines Consumption Value by Country (2019-2030)
6.3.2 United States Dengue Vaccines Market Size and Forecast (2019-2030)
6.3.3 Canada Dengue Vaccines Market Size and Forecast (2019-2030)
6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Dengue Vaccines Consumption Value by Type (2019-2030)
7.2 Europe Dengue Vaccines Consumption Value by Application (2019-2030)
7.3 Europe Dengue Vaccines Market Size by Country
7.3.1 Europe Dengue Vaccines Consumption Value by Country (2019-2030)
7.3.2 Germany Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.3 France Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.5 Russia Dengue Vaccines Market Size and Forecast (2019-2030)
7.3.6 Italy Dengue Vaccines Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Dengue Vaccines Market Size by Region
8.3.1 Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2030)
8.3.2 China Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.3 Japan Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.5 India Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2019-2030)
8.3.7 Australia Dengue Vaccines Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Dengue Vaccines Consumption Value by Type (2019-2030)
9.2 South America Dengue Vaccines Consumption Value by Application (2019-2030)
9.3 South America Dengue Vaccines Market Size by Country
9.3.1 South America Dengue Vaccines Consumption Value by Country (2019-2030)
9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2019-2030)
9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Dengue Vaccines Market Size by Country
10.3.1 Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2030)
10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2019-2030)
10.3.4 UAE Dengue Vaccines Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Dengue Vaccines Market Drivers
11.2 Dengue Vaccines Market Restraints
11.3 Dengue Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Dengue Vaccines Industry Chain
12.2 Dengue Vaccines Upstream Analysis
12.3 Dengue Vaccines Midstream Analysis
12.4 Dengue Vaccines Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Dengue Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Dengue Vaccines Product and Solutions
Table 8. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Takeda Company Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Dengue Vaccines Product and Solutions
Table 13. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Takeda Recent Developments and Future Plans
Table 15. Global Dengue Vaccines Revenue (USD Million) by Players (2019-2024)
Table 16. Global Dengue Vaccines Revenue Share by Players (2019-2024)
Table 17. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Dengue Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 19. Head Office of Key Dengue Vaccines Players
Table 20. Dengue Vaccines Market: Company Product Type Footprint
Table 21. Dengue Vaccines Market: Company Product Application Footprint
Table 22. Dengue Vaccines New Market Entrants and Barriers to Market Entry
Table 23. Dengue Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Dengue Vaccines Consumption Value (USD Million) by Type (2019-2024)
Table 25. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
Table 26. Global Dengue Vaccines Consumption Value Forecast by Type (2025-2030)
Table 27. Global Dengue Vaccines Consumption Value by Application (2019-2024)
Table 28. Global Dengue Vaccines Consumption Value Forecast by Application (2025-2030)
Table 29. North America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 30. North America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 31. North America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 32. North America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 33. North America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 34. North America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 35. Europe Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Europe Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Europe Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 38. Europe Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 39. Europe Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 40. Europe Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 41. Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Asia-Pacific Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 44. Asia-Pacific Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 45. Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 46. Asia-Pacific Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 47. South America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 48. South America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 49. South America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 50. South America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 51. South America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 52. South America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 54. Middle East & Africa Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 55. Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 56. Middle East & Africa Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 57. Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 58. Middle East & Africa Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Dengue Vaccines Raw Material
Table 60. Key Suppliers of Dengue Vaccines Raw Materials
Table 1. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Dengue Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Dengue Vaccines Product and Solutions
Table 8. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Takeda Company Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Dengue Vaccines Product and Solutions
Table 13. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Takeda Recent Developments and Future Plans
Table 15. Global Dengue Vaccines Revenue (USD Million) by Players (2019-2024)
Table 16. Global Dengue Vaccines Revenue Share by Players (2019-2024)
Table 17. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Dengue Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 19. Head Office of Key Dengue Vaccines Players
Table 20. Dengue Vaccines Market: Company Product Type Footprint
Table 21. Dengue Vaccines Market: Company Product Application Footprint
Table 22. Dengue Vaccines New Market Entrants and Barriers to Market Entry
Table 23. Dengue Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Dengue Vaccines Consumption Value (USD Million) by Type (2019-2024)
Table 25. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
Table 26. Global Dengue Vaccines Consumption Value Forecast by Type (2025-2030)
Table 27. Global Dengue Vaccines Consumption Value by Application (2019-2024)
Table 28. Global Dengue Vaccines Consumption Value Forecast by Application (2025-2030)
Table 29. North America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 30. North America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 31. North America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 32. North America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 33. North America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 34. North America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 35. Europe Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 36. Europe Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 37. Europe Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 38. Europe Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 39. Europe Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 40. Europe Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 41. Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 42. Asia-Pacific Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 43. Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 44. Asia-Pacific Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 45. Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 46. Asia-Pacific Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 47. South America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 48. South America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 49. South America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 50. South America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 51. South America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 52. South America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 53. Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 54. Middle East & Africa Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 55. Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 56. Middle East & Africa Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 57. Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 58. Middle East & Africa Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 59. Dengue Vaccines Raw Material
Table 60. Key Suppliers of Dengue Vaccines Raw Materials
LIST OF FIGURES
Figure 1. Dengue Vaccines Picture
Figure 2. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Dengue Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Dengvaxia
Figure 5. TAK-003
Figure 6. Others
Figure 7. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Dengue Vaccines Consumption Value Market Share by Application in 2023
Figure 9. Public Sector Picture
Figure 10. Private Sector Picture
Figure 11. Global Dengue Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Dengue Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Dengue Vaccines Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Dengue Vaccines Consumption Value Market Share by Region in 2023
Figure 16. North America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Dengue Vaccines Revenue Share by Players in 2023
Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Dengue Vaccines Market Share in 2023
Figure 24. Global Top 6 Players Dengue Vaccines Market Share in 2023
Figure 25. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
Figure 26. Global Dengue Vaccines Market Share Forecast by Type (2025-2030)
Figure 27. Global Dengue Vaccines Consumption Value Share by Application (2019-2024)
Figure 28. Global Dengue Vaccines Market Share Forecast by Application (2025-2030)
Figure 29. North America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 39. France Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 46. China Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 49. India Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 63. Dengue Vaccines Market Drivers
Figure 64. Dengue Vaccines Market Restraints
Figure 65. Dengue Vaccines Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dengue Vaccines in 2023
Figure 68. Manufacturing Process Analysis of Dengue Vaccines
Figure 69. Dengue Vaccines Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Dengue Vaccines Picture
Figure 2. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Dengue Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Dengvaxia
Figure 5. TAK-003
Figure 6. Others
Figure 7. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Dengue Vaccines Consumption Value Market Share by Application in 2023
Figure 9. Public Sector Picture
Figure 10. Private Sector Picture
Figure 11. Global Dengue Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Dengue Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Dengue Vaccines Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Dengue Vaccines Consumption Value Market Share by Region in 2023
Figure 16. North America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Dengue Vaccines Revenue Share by Players in 2023
Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Dengue Vaccines Market Share in 2023
Figure 24. Global Top 6 Players Dengue Vaccines Market Share in 2023
Figure 25. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
Figure 26. Global Dengue Vaccines Market Share Forecast by Type (2025-2030)
Figure 27. Global Dengue Vaccines Consumption Value Share by Application (2019-2024)
Figure 28. Global Dengue Vaccines Market Share Forecast by Application (2025-2030)
Figure 29. North America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 39. France Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 46. China Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 49. India Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 63. Dengue Vaccines Market Drivers
Figure 64. Dengue Vaccines Market Restraints
Figure 65. Dengue Vaccines Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dengue Vaccines in 2023
Figure 68. Manufacturing Process Analysis of Dengue Vaccines
Figure 69. Dengue Vaccines Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
